Delphx Cap Mkts Stock Price, News & Analysis

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF), a fixed income structured products developer, has completed a non-brokered private placement raising C$251,040 through the issuance of 2,789,333 units at C$0.09 per unit. Each unit comprises one common share and one purchase warrant, with warrants exercisable at C$0.20 per share for a two-year period.

The offering has received conditional acceptance from the TSX Venture Exchange, pending final requirements. Securities issued will have a four-month plus one-day hold period. The company plans to use the proceeds for general corporate purposes.

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) has completed a non-brokered private placement, raising C$160,200 through the issuance of 1,335,000 units at C$0.12 per unit. Each unit comprises one common share and one purchase warrant, with warrants exercisable at C$0.20 per share for five years.

Insiders participated by subscribing for 85,000 units, making this a 'related party transaction.' The company received conditional acceptance from the TSX Venture Exchange, with final acceptance pending. Securities issued will have a four-month plus one-day hold period. The proceeds will be used for general corporate purposes.

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF), a company focused on developing structured products for the fixed income market, has announced a new stock option grant. The Board of Directors has approved 1,750,000 stock options for eligible participants under its stock option plan. These options come with a two-year maturity period and can be exercised at $0.20 per common share.

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) has announced significant achievements in 2024 and outlined its growth strategy for 2025. The company is preparing to execute its first commercial transactions in Q1 2025, involving downgrade protection coverage on a $3 billion notional value bond portfolio.

The company's Credit Rating Securities (CRS) program has received positive feedback from hedge funds and institutional buyers, with active term sheets already exchanged between parties. This innovative platform enables insurance companies, hedge funds, and institutional investors to manage downgrade risks while generating new returns.

CEO Patrick Wood emphasized that DelphX is delivering the most significant innovation in fixed income markets in over a decade, with the company positioned for increased CRS adoption and positive cash flows in 2025.

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) has completed its previously announced non-brokered private placement, raising C$348,100 through the issuance of 2,900,834 units at C$0.12 per unit. Each unit includes one common share and one purchase warrant, exercisable at C$0.20 for five years.

Insiders participated by subscribing for 420,000 units. AlphaNorth Asset Management will receive C$3,528 in finder's fees and 29,400 finders' warrants. The offering, conditionally accepted by TSX Venture Exchange, includes a four-month plus one day hold period for issued securities. Proceeds will be used for general corporate purposes.

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) announces the issuance of 428,571 common shares at a deemed price of C$0.14 per share to a consultant. The shares, valued at C$60,000, are being issued as payment for services related to the Company's Credit Rating Security (CRS) product, including refinement of pricing models, preparation of presentations, and assistance with broker dealer negotiations. Following the issuance, which requires TSX Venture Exchange approval, DelphX will have 182,102,033 common shares outstanding.

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) announced it will issue 138,888 common shares to a consultant as payment for services related to securing a non-binding letter of intent with hedge funds for up to $3 billion of notional credit spread protection through their CRS program. The shares will be issued at $0.18 per share, totaling C$25,000. Following the issuance, which requires TSX Venture Exchange approval, DelphX will have 181,812,350 common shares outstanding. The shares will be issued as restricted securities under U.S. Securities Act exemptions.

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) announces a non-brokered private placement to raise C$348,100 through the issuance of 2,900,833 units at C$0.12 per unit. Each unit includes one common share and one purchase warrant exercisable at C$0.20 for five years. The company will pay cash finder's fees and issue finders' warrants to eligible finders. The offering requires TSX Venture Exchange approval and includes a four-month plus one-day hold period. Proceeds will be used for general corporate purposes.

DelphX Capital Markets (TSXV: DELX) (OTCQB: DPXCF) announces plans to seek TSX Venture Exchange approval to extend the exercise period of 5,422,221 share purchase warrants by one year to December 7, 2025. The warrants, originally issued in a December 2022 private placement, are exercisable at $0.15 per common share. Of these warrants, 1,611,111 are held by related parties, constituting a related party transaction. The transaction is exempt from formal valuation and minority approval requirements as the warrants' fair market value is below 25% of DelphX's market capitalization.